Tailored thinking training may ease psychosis symptoms

NCT ID NCT07146802

Not yet recruiting Symptom relief Sponsor: University Hospital, Strasbourg, France Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study compares standard metacognitive training (MCT) with a personalized version (P-MCT) for people with schizophrenia spectrum disorder. The goal is to see which approach better improves daily functioning and reduces symptoms. Fifty-one adults with stable psychosis will take part, and the therapy will be tailored using machine learning.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Metacognitive Training (MCT) and personalized Metacognitive Training (P-MCT)
What this could lead to: If successful, this could show that tailoring psychological therapy to each person's thinking patterns helps them function better in daily life.
What could go wrong: This is a small, early-stage study (51 people) that hasn't started yet. It tests a behavioral intervention, not a drug, so results may be modest and not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA SPECTRUM DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

psychotic disorder schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SCHIZOPHRENIA SPECTRUM DISORDER

More trials for these conditions

Other studies related to the condition(s) this trial covers.